Status:
COMPLETED
The Impact of Olive Oil Polyphenol Supplementation on Metabolic Syndrome Parameters: Preclinical Investigations Have Demonstrated That Olive Oil Polyphenols, Notably Oleocanthal, Oleacein, and Allied Secoiridoids, Possess Anti-inflammatory and Antioxidant Attributes
Lead Sponsor:
Apostolos Loukas Medical Centre Cyprus
Collaborating Sponsors:
University of Nicosia
University of Crete
Conditions:
Metabolic Syndrome
Eligibility:
All Genders
30-70 years
Phase:
NA
Brief Summary
Olive oil polyphenols, particularly oleocanthal, oleacein, and related secoiridoids, have shown anti-inflammatory and antioxidant properties in preclinical studies. Metabolic syndrome (MetS) is charac...
Eligibility Criteria
Inclusion
- Adults aged 30-70 years with a diagnosis of MetS per International Diabetes Federation criteria were enrolled after informed consent.
Exclusion
- \-
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2025
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT07144488
Start Date
September 1 2024
End Date
January 1 2025
Last Update
August 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Apostolos Loukas Medical Centre Cyprus
Nicosia, Engomi, Cyprus